₨ NPR
EMPACARE 25
Empacare 25 mg contains empagliflozin, used to manage type 2 diabetes, heart failure, and chronic kidney disease. It works by helping the kidneys remove excess glucose through urine. Common side effects include increased urination and urinary tract infections. It is not suitable for type 1 diabetes or severe kidney issues.
₨700.00
Ask about productDescription
Main Uses:
- Type 2 Diabetes Management: Helps lower blood sugar levels when used alongside diet and exercise.
- Cardiovascular Risk Reduction: Reduces the risk of cardiovascular death in adults with type 2 diabetes and established heart disease.
- Heart Failure Treatment: Indicated for adults with symptomatic chronic heart failure.
- Chronic Kidney Disease Management: Used in adults for the treatment of chronic kidney disease.
How It Works:
Empagliflozin belongs to the SGLT2 inhibitor class of medications. It functions by preventing the kidneys from reabsorbing glucose back into the bloodstream, leading to increased glucose excretion through urine and thereby lowering blood sugar levels.
Dosage:
- The typical starting dose is 10 mg once daily, which may be increased to 25 mg once daily based on individual response and tolerability.
Precautions:
- Not for Type 1 Diabetes: Empagliflozin is not recommended for patients with type 1 diabetes or for treating diabetic ketoacidosis.
- Renal Function Monitoring: Regular monitoring of kidney function is advised, as the medication is less effective in patients with severe kidney impairment.
- Risk of Hypotension: May cause low blood pressure, especially in patients on diuretics or with low blood volume.
Side Effects:
- Common: Urinary tract infections, increased urination, and thirst.
- Serious: Dehydration, ketoacidosis, and kidney issues.
Additional information
| form | Oral Tablets |
|---|
Reviews
There are no reviews yet.